SCG

SCG's mission is to harness the patient's immune system to target pathogenic infections or related antigens for the prevention and treatment of cancer. Committed to advancing innovative immunotherapies to benefit patients with pathogenic infections and associated cancers. SCG combines internal R&D with external collaborations to discover and develop novel immunotherapies for patients with unmet medical needs.